HLA-DQA1, major histocompatibility complex, class II, DQ alpha 1, 3117
N. diseases: 427; N. variants: 101
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.080 | 6 | 32634619 | intron variant | C/T | snv |
|
Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
1.000 | 0.040 | 6 | 32635879 | intron variant | C/A;G | snv |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 6 | 32635879 | intron variant | C/A;G | snv |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 6 | 32628470 | intron variant | G/T | snv | 5.0E-02 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 6 | 32632691 | intron variant | G/A | snv | 5.9E-02 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
6 | 32632808 | 5 prime UTR variant | G/A | snv | 6.9E-02 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
1.000 | 0.040 | 6 | 32633277 | intron variant | C/A;G | snv | 5.0E-02 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.925 | 0.160 | 6 | 32636021 | intron variant | A/C;T | snv |
|
Infections; Respiratory Tract Diseases; Otorhinolaryngologic Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.925 | 0.160 | 6 | 32636021 | intron variant | A/C;T | snv |
|
Pathological Conditions, Signs and Symptoms; Respiratory Tract Diseases; Otorhinolaryngologic Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
1.000 | 0.080 | 6 | 32630251 | intron variant | C/T | snv | 5.7E-02 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.080 | 6 | 32630251 | intron variant | C/T | snv | 5.7E-02 |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
6 | 32640505 | intron variant | -/A;GAA | delins |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||||
|
1.000 | 0.040 | 6 | 32638205 | intron variant | -/A;G | ins |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
1.000 | 0.040 | 6 | 32631878 | intron variant | T/C | snv |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 6 | 32631878 | intron variant | T/C | snv |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.120 | 6 | 32634653 | intron variant | C/A | snv | 0.26 |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2007 | 2007 | |||||||
|
1.000 | 0.120 | 6 | 32634653 | intron variant | C/A | snv | 0.26 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.925 | 0.120 | 6 | 32652506 | intergenic variant | C/T | snv | 0.49 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 6 | 32654605 | downstream gene variant | T/C | snv |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 6 | 32654605 | downstream gene variant | T/C | snv |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 6 | 32637642 | intron variant | -/T | ins |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
6 | 32644683 | non coding transcript exon variant | G/A | snv | 0.22 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
1.000 | 0.040 | 6 | 32628532 | intron variant | C/T | snv | 0.76 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.882 | 0.240 | 6 | 32635230 | intron variant | A/G | snv | 0.23 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.882 | 0.240 | 6 | 32635230 | intron variant | A/G | snv | 0.23 |
|
Digestive System Diseases; Neoplasms | 0.700 | 1.000 | 1 | 2013 | 2013 |